BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare

Financial Overview

Latest Annual: 2019

Income Metrics

Revenue 26.4M
Gross Profit -7.2M -27.22%
Operating Income -41.4M -157.01%
Net Income -42.9M -162.49%

Balance Sheet Metrics

Total Assets 185.7M
Total Liabilities 141.2M
Shareholders Equity 44.5M
Debt to Equity 3.18

Cash Flow Metrics

Operating Cash Flow -47.4M
Free Cash Flow -42.7M

Revenue & Profitability Trend

BNP Paribas Easy Income Statement From 2015 to 2019

Metric20192018201720162015
Revenue26.4M38.2M80.7M109.3M121.9M
Cost of Goods Sold33.6M34.6M61.3M69.5M81.3M
Gross Profit-7.2M3.6M19.4M39.9M40.5M
Operating Expenses-10.2M-9.5M-9.0M-8.4M-7.7M
Operating Income-41.4M-30.4M-19.7M-299.0K3.8M
Pre-tax Income-42.3M-32.7M-21.2M1.3M508.0K
Income Tax568.0K690.0K-2.0M1.3M488.0K
Net Income-42.9M-33.4M-19.2M-80.0K20.0K
EPS (Diluted)--€1.14-€0.67€0.00€0.00

Income Statement Trend

BNP Paribas Easy Balance Sheet From 2015 to 2019

Metric20192018201720162015
Assets
Current Assets34.7M30.0M35.9M54.1M62.9M
Non-Current Assets151.0M145.1M149.3M157.0M133.0M
Total Assets185.7M175.1M185.1M211.2M195.9M
Liabilities
Current Liabilities82.2M41.9M21.4M19.9M22.5M
Non-Current Liabilities59.1M45.5M45.9M52.9M37.7M
Total Liabilities141.2M87.4M67.3M72.8M60.2M
Equity
Total Shareholders Equity44.5M87.7M117.8M138.4M135.7M

Balance Sheet Composition

BNP Paribas Easy Cash Flow Statement From 2015 to 2019

Metric20192018201720162015
Operating Activities
Net Income-42.9M-33.4M-19.2M-80.0K20.0K
Operating Cash Flow-47.4M-26.2M-8.1M5.5M-2.0M
Investing Activities
Capital Expenditures-8.9M-6.0M-12.0M-15.6M-15.1M
Investing Cash Flow-8.8M-5.5M-11.9M-23.4M-15.2M
Financing Activities
Dividends Paid-----
Financing Cash Flow1.3M1.3M--59.0K
Free Cash Flow-42.7M-19.0M-9.0M1.7M2.0M

Cash Flow Trend

BNP Paribas Easy Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.91
Price to Sales 17.32

Profitability Ratios

Profit Margin -27.22%
Operating Margin -156.86%
Return on Equity -96.39%
Return on Assets -23.08%

Financial Health

Current Ratio 0.42
Debt to Equity 2.22

Per Share Data

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
blue456.7M15.91--96.39%-27.22%2.22
Medincell S.A 565.5M-18.81-61.33%-66.50%-1.44
Valneva SE 409.5M70.642.11-44.11%-43.21%120.48
Abivax SA 331.7M-1.96-52.78-196.12%0.00%-16.16
Inventiva S.A 379.0M-0.88-0.99172.73%0.00%-1.70
Viridian 415.4M50.430.400.93%2.05%103.04

Financial data is updated regularly. All figures are in the company's reporting currency.